Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark Pharma
Markets traded subdued on the weekly expiry day, with indices ending marginally lower. Cochin Shipyard's offer for sale saw strong investor demand on its first day. Adani Enterprises' US legal case faces a likely dismissal by federal prosecutors. IDFC First Bank launched provident fund payment services through its EPFO integration. Premier Energies secured significant orders, and Glenmark Pharma launched a generic drug in the US.
Glenmark Pharmaceuticals Ltd stays supported
Glenmark Pharmaceuticals Ltd is quoting at Rs 2260.5, up 2.24% on the day as on 12:49 IST on the NSE. The stock is up 21.53% in last one year as compared to a 4.02% slide in NIFTY and a 15.14% slide in the Nifty Pharma index.
Glenmark Pharmaceuticals receives six observations after US FDA inspection of Goa plant
Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,204.90, down by ₹18.70, or 0.86%, on the BSE.
Glenmark Pharma Profit Expected To Soar 5x in Two Years, Says Motilal Oswal — Check Target Price
Glenmark Pharma's shares are likely to remain in focus after Motilal Oswal has reiterated its positive stance on the stock.
Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom
Securities in F&O Ban:
After a dull Q4, Glenmark Pharma needs a booster shot to grow
Investors are shifting their focus to core operational execution as the drugmaker looks past one-off licensing gains to drive its FY27 growth.
Glenmark Pharma Q4 net profit zooms to ₹301 crore; recommends 250% dividend
Glenmark's Q4FY26 profit surged to ₹301.4 crore, marking a rise of over 6,400% from ₹4.6 crore a year earlier. Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,274.25, down by ₹108.40, or 4.55%, on the BSE today, May 30.
Glenmark Pharma Q4 Result: Net Profit Soars 64 Times, Revenue Rises; Dividend Declared
Revenue from operations jumped 15.8% to 3,771 crore in the quarter under review.
Q4 results today: Asian Paints, IndiGo, IREDA, Glenmark Pharma - 131 companies to announce earnings on 29 May
A total of 131 companies are slated to announce Q4 results on May 29, including Asian Paints and IndiGo. Analysts predict weak performance for Asian Paints due to urban demand issues, while NMDC's results may reveal vital industry insights on iron ore prices and demand trends.
Stocks to Watch today: RIL, Lupin, Wipro, Asian Paints, Ireda,Tata Elxsi
Stocks to Watch today, May 29, 2026: Ashok Leyland, Alkem Laboratories, PhysicsWallah, GMR Airports, InterGlobe Aviation, NMDC, and Glenmark Pharma are among the top stocks to remain in focus today
Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment
The Indian stock market is set to open lower, with the Gift Nifty at 23,882, down 97 points. Benchmark indices fell on profit-taking and rising crude oil prices, leading to cautious sentiment. Nifty 50 faces immediate hurdles at 24,100 and support at 23,800.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail: